Dapagliflozin + Elecoglipron for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jun 2026: Trial registered, NCT07662044
  2. 6 Jul 2026: Trial started, NCT07662044

The trials

NCT07662044: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

State
Under way
Phase
Phase 3
People
800 planned
Started
6 Jul 2026
Primary completion
14 Jul 2028
Arms
Elecoglipron (one of the studied dose levels) + dapagliflozin
Results
None posted
  1. 23 Jun 2026: Trial registered
  2. 6 Jul 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.